Last reviewed · How we verify

D013, placebo of D326, placebo of D337

Chong Kun Dang Pharmaceutical · Phase 3 active Small molecule

D013, placebo of D326, placebo of D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 3 development. Also known as: Drugs are consist of antihypertensive agent and antihyperlipidemic agent.

D013 is a placebo control formulation with no active pharmacological mechanism.

At a glance

Generic nameD013, placebo of D326, placebo of D337
Also known asDrugs are consist of antihypertensive agent and antihyperlipidemic agent
SponsorChong Kun Dang Pharmaceutical
ModalitySmall molecule
PhasePhase 3

Mechanism of action

As a placebo of D326 and D337, D013 contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials. It is designed to match the appearance and administration route of the active investigational drugs while providing no therapeutic effect, allowing for blinded assessment of efficacy and safety.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about D013, placebo of D326, placebo of D337

What is D013, placebo of D326, placebo of D337?

D013, placebo of D326, placebo of D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.

How does D013, placebo of D326, placebo of D337 work?

D013 is a placebo control formulation with no active pharmacological mechanism.

Who makes D013, placebo of D326, placebo of D337?

D013, placebo of D326, placebo of D337 is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).

Is D013, placebo of D326, placebo of D337 also known as anything else?

D013, placebo of D326, placebo of D337 is also known as Drugs are consist of antihypertensive agent and antihyperlipidemic agent.

What development phase is D013, placebo of D326, placebo of D337 in?

D013, placebo of D326, placebo of D337 is in Phase 3.

Related